Cellectis Announces Participation in Four Upcoming Investor Conferences in September

Published on September 01, 2022 in New York, NY

Back to all press releases

New York, NY – September 1, 2022 – Cellectis (the “Company”) (Euronext Growth: ALCLS - NASDAQ: CLLS), a clinical-stage biotechnology company using its pioneering gene-editing platform to develop life-saving cell and gene therapies, today announced that management plans to participate in four upcoming investor conferences.

Details for the events are below:

Citi's 17th Annual Biopharma Conference

Format: Panel

Date: September 7th, 2022

Time: 9:40AM- 10:25AM ET

Location: Four Seasons Hotel, Boston, MA

Webcast Link: http://www.veracast.com/webcasts/citigroup/biopharma2022/3DniPm.cfm

Wells Fargo 2022 Healthcare Conference

Format: Investor meetings

Date: September 7-9, 2022

Location: Encore Boston Harbor, Everett, MA


Baird Global Healthcare Conference

Format: Presentation

Date: September 13, 2022

Time: 10:15AM-10:45AM ET

Location: Intercontinental Barclay Hotel, New York City, NY


Jefferies Cell and Genetic Medicine Summit

Format: Presentation

Date: September 29, 2022

Time: Presentation time to be posted on Cellectis.com

Location: Palace Hotel, New York City, NY


Live webcasts and replays of these presentations will be available under the “Events and Webcasts” section on the Investor page of the of the Company’s website: https://cellectis.com/en/investors/events-and-webcasts/

Download the PDF file